Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity (Q45788517)
scientific article published on November 1, 1995
Language:
(P31) (Q13442814)
(P304) 3287-3294
(P407) (Q1860)
(P433) 9
(P478) 86
(P577) Wednesday, November 1, 1995
(P953) http://www.bloodjournal.org/cgi/content/abstract/86/9/3287
(P1433) (Q885070)
(P1476) "Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity" (language: en)
(P2093) Z. P. Bernstein
M. M. Porter
M. Gould
B. Lipman
E. M. Bluman
C. C. Stewart
R. G. Hewitt
G. Fyfe
B. Poiesz
M. A. Caligiuri
other details
description scientific article published on November 1, 1995

External Links